Cancers following thoracic organ transplantation: a single center study.
Burtin
P
P
Département d'anesthésie, Laboratoire d'Anatomie Pathologique, Nancy, France.
Boman
F
F
Pinelli
G
G
Mattei
M F
MF
Dopff
C
C
Villemot
J P
JP
D005500:Follow-Up Studies; D016027:Heart Transplantation / Q000276:immunology*; D016041:Heart-Lung Transplantation / Q000276:immunology*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008228:Lymphoma, Non-Hodgkin / Q000453:epidemiology; D008875:Middle Aged; D016853:Muromonab-CD3 / Q000009:adverse effects / Q000627:therapeutic use; D009369:Neoplasms / Q000453:epidemiology* / Q000209:etiology; D012189:Retrospective Studies; D012307:Risk Factors; D012878:Skin Neoplasms / Q000453:epidemiology; D013997:Time Factors
D007166:Immunosuppressive Agents; D016853:Muromonab-CD3